Emergent BioSolutions Inc (EBS)

10.09 -0.19 (-1.85%) USD  |  NYSE  |  Jan 08, 16:00
9.91 -0.18 (-1.78%) After-Hours: 20:00
More

Emergent BioSolutions Research and Development Expense (Annual): 111.40M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for EBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Abbott Laboratories 2.741B
Tonix Pharmaceuticals Holding Corp 86.66M
Chimerix Inc 68.79M
Marinus Pharmaceuticals Inc 99.39M
MAIA Biotechnology Inc 11.11M